Cite
HARVARD Citation
Dreesen, E. et al. (2020). A Population Pharmacokinetic and Exposure–Response Model of Golimumab for Targeting Endoscopic Remission in Patients With Ulcerative Colitis. Inflammatory bowel diseases. 26 (4), pp. 570-580. [Online].